SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-033684
Filing Date
2024-03-13
Accepted
2024-03-13 06:14:57
Documents
15
Period of Report
2024-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm248678d1_8k.htm   iXBRL 8-K 24740
2 EXHIBIT 99.1 tm248678d1_ex99-1.htm EX-99.1 57742
  Complete submission text file 0001104659-24-033684.txt   266479

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lqda-20240313.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20240313_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20240313_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT tm248678d1_8k_htm.xml XML 3583
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 24744516
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)